Drug Target Review – Publications

Our next issue

Coming up in the Winter Edition of Drug Target Review…

• Leveraging the power of HTS in the new and rapidly evolving collaborative drug discovery landscape
• Evaluate drug candidates early by testing critical quality attributes
• The role of drug transporters in phenotypic screening 
• Omics-informed drug target discovery in combating emerging infectious diseases
• Beyond ‘simple’ biology – turning organoids, spheroids, and 3D tissue models into physiologically relevant high-content assays for drug discovery

Also three In-Depth Focuses covering:

• Hit-to-Lead
• Screening
• Targets

Our journal will be released at the end of November.

Latest issue

Issue #3 2018

Drug Target Review – Issue 3 2018

Issue #3 2018

Applications of high content screening in autophagy

Issue #3 2018

Complex biology for the precision medicine era: re-thinking the drug discovery process

Issue #3 2018

Upstream cell culture processes for the production of therapeutic proteins

Issue #3 2018

The evolving role of three-dimensional in vitro cell culture techniques in drug discovery

Issue #3 2018

Human iPSC-derived functional cells are revolutionising phenotypic drug discovery and development

Issue #3 2018

Expert view: New developments in real‑time live‑cell analysis

Issue #3 2018

Application Note: Evaluating the specificity and potency of PD-1 and PD-L1 blocking antibodies using AlphaLISA human and mouse PD-1/PD-L1 binding kits

Issue #3 2018

Expert view: Managing the complexity of finding new targets and drugging the undruggable

Issue #3 2018

Monoclonal antibody discovery: current status and future perspectives

Issue #3 2018

Aggregate formation for monoclonal antibodies

Issue #3 2018

Expert view: Assays to measure the potency of therapeutic antibodies used in combination with other drugs for Immuno‑Oncology treatments

Issue #3 2018

Application Note: Full-length, single-cell RNA-seq with the SMARTer™ ICELL8® Single-Cell System

Issue #3 2018

Antibodies In-Depth Focus 2018

Issue #3 2018

Expert view: GMP proteins for therapeutic manufacturing: combining consistency, safety, and supply

Issue #3 2018

Expert view: Large‑scale stem cell expansion and differentiation

Issue #3 2018

Assays In-Depth Focus 2018

Issue #3 2018

The rise of high-throughput flow cytometry in drug discovery

Issue #3 2018

Using bioactivity profiling to support the progression of phenotypic hits

Issue #3 2018

Next-Generation Sequencing In-Depth Focus 2018

Issue #3 2018

Expert view: Multiplexed screens in biologics discovery

Issue #3 2018

How recent advances in flow cytometry can aid drug discovery

Issue #3 2018

NGS: hunting mysterious ‘Dark Matter Genome’ towards rewriting the rules of human genetic diseases

Issue #3 2018

Flow Cytometry In-Depth Focus 2018

Issue #3 2018

Upstream Bioprocessing In-Depth Focus 2018

Issue #3 2018

Expert view: Screen everything. See everything.

Issue #3 2018

Recent advances in diagnostics and treatments – from small molecules to cellular therapies

Issue #3 2018

Expert view: Unravelling the complexities of GABAA subunit selectivity in drug discovery

Issue #3 2018

Expert view: Tools for compliance with 21 CFR Part 11

Issue #3 2018

Expert view: Generate high‑content information using flow cytometry

Issue #3 2018

Expert view: Challenges in flow cytometry

Issue #3 2018

NGS: enabling biomarker discovery at single-cell resolution

Issue #3 2018

Cell-based and biochemical high-throughput screening in 1536 well plates

Issue #3 2018

Expert view: The development of single‑cell genomics with Smart‑seq

Issue #3 2018

Improved screening of therapeutic candidates using integrated fragment-based approaches

Issue #3 2018

Synthetic biology in drug discovery

Issue #3 2018

Pharmacological targeting of mitochondrial dysfunction in Parkinson’s disease: approaches and perspectives

Issue #3 2018

Metabolomics in drug and biomarker discovery

Past Issues

Issue #2 2018

Drug Target Review – Issue #2 2018

Issue #1 2018

Drug Target Review – Issue #1 2018

Issue #4 2017

Drug Target Review – Issue #4 2017

Issue #3 2017

Drug Target Review – Issue #3 2017

Issue #2 2017

Drug Target Review – Issue #2 2017

Issue #1 2017

Drug Target Review – Issue #1 2017

Issue #4 2016

Drug Target Review – Issue #4 2016

Issue #3 2016

Drug Target Review – Issue #3 2016

Issue #2 2016

Drug Target Review – Issue #2 2016

Issue #1 2016

Drug Target Review – Issue #1 2016

Issue #4 2015

Drug Target Review – Issue #4 2015

Issue #3 2015

Drug Target Review – Issue #3 2015

Issue #2 2015

Drug Target Review – Issue #2 2015

Issue #1 2015

Drug Target Review – Issue #1 2015

Issue #1 2014

Drug Target Review – Issue #1 2014

Supplements & Special Editions

Issue #3 2018

Upstream Bioprocessing In-Depth Focus 2018

Issue #3 2018

Flow Cytometry In-Depth Focus 2018

Issue #3 2018

Next-Generation Sequencing In-Depth Focus 2018

Issue #3 2018

Assays In-Depth Focus 2018

Issue #3 2018

Antibodies In-Depth Focus 2018

Issue #2 2018

Screening In-Depth Focus 2018

Issue #2 2018

Imaging In-Depth Focus 2018

Issue #2 2018

Stem Cells In-Depth Focus 2018

Issue #1 2018

Lab Automation In-Depth Focus 2018

Issue #1 2018

Informatics In-Depth Focus 2018

Issue #1 2018

Assays In-Depth Focus 2018

Issue #4 2017

Screening In-Depth Focus 2017

Issue #4 2017

Informatics In-Depth Focus 2017

Issue #4 2017

Hit To Lead In-Depth Focus 2017

Issue #3 2017

NGS In-Depth Focus 2017